Cargando…

Apparent inefficacy of hydroxychloroquine combined with azithromycin on SARS-CoV-2 clearance in an incident cohort of geriatric patients with COVID-19

Detalles Bibliográficos
Autores principales:	Mazzitelli, Maria, Davoli, Chiara, Scaglione, Vincenzo, Fusco, Paolo, La Gamba, Valentina, Matera, Giovanni, Trecarichi, Enrico Maria, Torti, Carlo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2020
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7392844/ https://www.ncbi.nlm.nih.gov/pubmed/32739472 http://dx.doi.org/10.1016/j.tmaid.2020.101826

Ejemplares similares

Virological and Clinical Outcome of DAA Containing Regimens in a Cohort of Patients in Calabria Region (Southern Italy)
por: Scaglione, Vincenzo, et al.
Publicado: (2020)

Dangers of the use of hydroxychloroquine and azithromycin combination in COVID-19 patients
por: Alizargar, Javad
Publicado: (2020)

Oxygen therapy via high flow nasal cannula in severe respiratory failure caused by Sars-Cov-2 infection: a real-life observational study
por: Procopio, Giada, et al.
Publicado: (2020)

Late-onset myocardial infarction and autoimmune haemolytic anaemia in a COVID-19 patient without respiratory symptoms, concomitant with a paradoxical increase in inflammatory markers: a case report
por: Pelle, Maria Chiara, et al.
Publicado: (2020)

Prevalence of Antibiotic Resistance Over Time in a Third-Level University Hospital
por: Scaglione, Vincenzo, et al.
Publicado: (2022)

Conflicting evidence on the efficacy of hydroxychloroquine and azithromycin as the early treatment of COVID-19. Comment on “Early treatment of COVID-19 patients with hydroxychloroquine and azithromycin: A retrospective analysis of 1061 cases in Marseille, France”
por: Bonny, Aimé, et al.
Publicado: (2020)

Clinical characteristics and predictors of mortality associated with COVID-19 in elderly patients from a long-term care facility
por: Trecarichi, Enrico Maria, et al.
Publicado: (2020)

Cardiovascular Toxicities Associated With Hydroxychloroquine and Azithromycin: An Analysis of the World Health Organization Pharmacovigilance Database
por: Nguyen, Lee S., et al.
Publicado: (2020)

Reply to Alizazgar J. Dangers of the use of hydroxychloroquine and azithromycin combination in COVID-19 patients
por: Honoré, Stéphane, et al.
Publicado: (2021)

A short focus, azithromycin in the treatment of respiratory viral infection COVID-19: efficacy or inefficacy?
por: Vitiello, Antonio, et al.
Publicado: (2021)

Potential implications of SARS-CoV-2 epidemic in Africa: where are we going from now?
por: Torti, Carlo, et al.
Publicado: (2020)

The inefficacy of antiangiogenic therapies
por: Ribatti, Domenico
Publicado: (2010)

Complete Clearance of Cutaneous Warts with Hydroxychloroquine: Antiviral Action?
por: Bhushan, Premanshu, et al.
Publicado: (2014)

Claims about the safety and efficacy of early treatment of COVID-19 with hydroxychloroquine and azithromycin must be supported by real evidence
por: Bigna, Jean Joel, et al.
Publicado: (2020)

In vitro Activity of Cefiderocol Against Carbapenem-Resistant Acinetobacter baumannii Clinical Isolates: a Single Center Experience
por: Quirino, Angela, et al.
Publicado: (2023)

Lacosamide: Inefficacy: case report
Publicado: (2021)

Effect of directly acting antivirals for hepatitis C virus infection on proprotein convertase subtilisin/kexin type 9 level
por: Torti, Carlo, et al.
Publicado: (2021)

A case report of pneumomediastinum in a COVID‐19 patient treated with high‐flow nasal cannula and review of the literature: Is this a “spontaneous” complication?
por: Cancelliere, Anna, et al.
Publicado: (2021)

Effect of hydroxychloroquine and azithromycin on the viral clearance of SARS-CoV-2: response to Hervé Seligmann
por: Gautret, Philippe, et al.
Publicado: (2021)

Effect of Combination Therapy of Hydroxychloroquine and Azithromycin on Mortality in Patients With COVID‐19
por: Lauriola, Marinella, et al.
Publicado: (2020)

Inefficacy of Antim. Tart. in the Cure of Ophthalmia
Publicado: (1814)

The Relative Inefficacy of Cacodylates as Therapeutic Agents
por: Fraser, Thomas R.
Publicado: (1902)

Spontaneous and Severe Haematomas in Patients with COVID-19 on Low- Molecular-Weight Heparin for Paroxysmal Atrial Fibrillation
por: Mazzitelli, Maria, et al.
Publicado: (2020)

Hydroxychloroquine- and azithromycin-related heart disorders
Publicado: (2020)

Hydroxychloroquine + azithromycin treatment in elderly patients
por: Gautret, Philippe, et al.
Publicado: (2021)

Hydroxychloroquine or chloroquine +/- azithromycin: heart disorders
Publicado: (2022)

No evidence of rapid antiviral clearance or clinical benefit with the combination of hydroxychloroquine and azithromycin in patients with severe COVID-19 infection
por: Molina, J.M., et al.
Publicado: (2020)

Effect of hydroxychloroquine and azithromycin on SARS-CoV-2 clearance in COVID-19 patients, a meta-analysis.
por: Million, Matthieu, et al.
Publicado: (2021)

Lessons learned and implications of early therapies for coronavirus disease in a territorial service centre in the Calabria region: a retrospective study
por: Scaglione, Vincenzo, et al.
Publicado: (2022)

Publisher Correction: Lessons learned and implications of early therapies for coronavirus disease in a territorial service centre in the Calabria region: a retrospective study
por: Scaglione, Vincenzo, et al.
Publicado: (2022)

Multidisciplinary approach to a septic COVID‐19 patient undergoing veno‐venous extracorporeal membrane oxygenation and receiving thoracic surgery
por: Bruni, Andrea, et al.
Publicado: (2021)

Role of the T2Dx magnetic resonance assay in patients with suspected bloodstream infection: a single-centre real-world experience
por: Quirino, Angela, et al.
Publicado: (2022)

QT interval prolongation with hydroxychloroquine plus azithromycin
Publicado: (2020)

Excessive lysosomal ion-trapping of hydroxychloroquine and azithromycin
por: Derendorf, Hartmut
Publicado: (2020)

Hydroxychloroquine-azithromycin for COVID-19 – Warranted or dangerous?
por: Popescu, Corneliu P., et al.
Publicado: (2020)

Hydroxychloroquine and azithromycin as a treatment of COVID-19
por: Fanin, Alice, et al.
Publicado: (2020)

Interleukin-6(2)/lymphocyte as a proposed predictive index for COVID-19 patients treated with monoclonal antibodies
por: Rotundo, Salvatore, et al.
Publicado: (2023)

Clinical, Virological Characteristics, and Outcomes of Treatment with Sofosbuvir/Ledipasvir in Two Pediatric Patients Infected by HCV Genotype 4
por: Marascio, Nadia, et al.
Publicado: (2019)

Bacterial Ventilator-Associated Pneumonia in COVID-19 Patients: Data from the Second and Third Waves of the Pandemic
por: Russo, Alessandro, et al.
Publicado: (2022)

Recent large-scale philophthalmosis outbreak in Portugal: inefficacy of common antihelminthic agents
por: Heneberg, Petr, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_v16e6s6lgm4ddgtcsij2rutne7